Sign Up for Our Newsletter!

Stay connected with ZERO Prostate Cancer through our newsletter below:

Name

🎁 $75,000 HOLIDAY MATCH IS LIVE🎁

Make a gift during the season of giving!

EOY Giving 2025 Match Your Gift

HELP 🔓 $100,000 IN LIFESAVING SUPPORT 💙

ONE DAY ONLY: Help ZERO raise $20,000

and unlock Harrity & Harrity's $80,000 match!

H4C EOY Giving Donate Now

Empowering You to Take Charge of Your Treatment

Patients living with advanced prostate cancer need to understand all of their options. In this webinar, a doctor and patient discussed what it's like to live with advanced prostate cancer, patient empowerment, immunotherapy as a treatment option, barriers to care, and the specifics of Provenge® , the only FDA-approved immunotherapy for metastatic castration-resistant prostate cancer (mCRPC).

The presentation and conversation featured Dr. Damian Sorce, M.D. and prostate cancer survivor, Mr. Euvon Jones. We will discuss living with prostate cancer, patient empowerment, immunotherapy as a treatment option, barriers to care, and the specifics of Provenge®, the only FDA-approved immunotherapy for mCRPC.

Meet our Presenters

Dr. Damian Sorce

Dr. Damian Sorce, M.D.

Director, Advanced Prostate Cancer Clinic
Euvon Jones

Euvon Jones

Patient

See More Videos

From webinars, to presentations at the ZERO Prostate Cancer Summit and Health Equity Symposium, to the "Ask the Doctor" series, patient stories, and archives of Facebook Live, learn about prostate cancer with ZERO's video libraries.

Brought to You in Partnership with:

Share